You have full text access to this Open Access content

Cancer Medicine

All articles accepted from 14 August 2012 are published under the terms of the Creative Commons Attribution License.  All articles accepted before this date, were published under a Creative Commons Attribution Non-Commercial License.

Cover image for Vol. 5 Issue 12

Edited By: Qingyi Wei, M.D., Ph.D.

Impact Factor: 2.915

ISI Journal Citation Reports © Ranking: 2015: 107/213 (Oncology)

Online ISSN: 2045-7634

Publishing with Cancer Medicine

Transfer your Manuscript or Submit Direct

Cancer Medicine is a peer reviewed, open access, interdisciplinary journal providing rapid publication of cutting-edge research from global biomedical researchers across the cancer sciences. The journal will consider submissions from all oncologic specialties, including, but not limited to, the following areas:
Cancer Biology: Molecular biology, cellular biology, molecular genetics, genomics, immunology, epigenetics, metabolic studies, proteomics, cytopathology, carcinogenesis, drug discovery and delivery
Clinical Cancer Research: Translational research, clinical trials, chemotherapy, radiation therapy, surgical therapy, clinical observations, clinical guidelines, genetic consultation, ethical considerations
Cancer Prevention: Behavioral science, psychosocial studies, screening, nutrition, epidemiology and prevention, community outreach

Cancer Medicine publishes original research articles, systematic reviews, meta-analyses, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented in the paper.

Cancer Medicine is a Wiley Open Access journal. All articles published by Cancer Medicine are fully open access: immediately freely available to read, download and share. To cover the cost of publishing, Cancer Medicine charges a publication fee.

Reasons to publish with Cancer Medicine:
• High standard, rigorous peer review
• Rapid publication
• Open Access – published articles are licensed under Creative Commons and authors are the copyright holder
• Compliant with open access mandates
• Wide dissemination
• Promotion and publicity of quality research
• Wiley’s tradition in publishing excellence

Submit your manuscript directly at

Wiley Open Access Manuscript Transfer Program
Cancer Medicine is supported by other journals published by Wiley including a number of society-owned journals. After review in a supporting Wiley journal, rejected articles of suitable quality can be identified by the Editor as candidates for publication in Cancer Medicine. Authors will have the option to automatically transfer their manuscript to Cancer Medicine and complete the submission process. The Cancer Medicine editors will then undertake further evaluation. Importantly, authors will not need to make any changes to their manuscript at this stage. Authors should note that referees’ comments are transferred to the editor of Cancer Medicine along with the manuscript. The Cancer Medicine editors will take the previous reviews into account when making their decision, although in some cases the editors may choose to take advice from additional referees.

For a list of Wiley journals that support and participate in the Wiley Open Access Manuscript Transfer program for Cancer Medicine click here.

Transfer your Manuscript

Have you been referred by another Wiley journal to Cancer Medicine?

If you have been directed to this website because your article has been referred by another Wiley journal and recommended as a strong candidate for publication in Cancer Medicine, please review the information on this website to help you reach a decision. If you would like to proceed and submit to the journal, please click the ‘Yes’ button below. Cancer Medicine’s editorial team will then quickly be in touch with an invitation to complete the submission for your paper and will automatically transfer your paper and accompanying peer-review reports into the Cancer Medicine submission site.

Yes, Transfer